Studies on combined experimental antitumor drug therapy. An attempt to overcoming the natural drug resistance

Biotechnology and Biotechnological Equipment

Volumn 16, Issue 1, 2002, Pages 138-141

  Ilarionova, M ^a   Todorov, D K ^a   Timcheva, K ^a   Dudov, A ^b  

^a National Oncology Center Bulgaria   (Bulgaria)

^b Sofia Cancer Centre   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

NAVELBINE; THALICARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESISTANCE; HELA CELL; HUMAN; HUMAN CELL; IC 50; LIFESPAN; LYMPHATIC LEUKEMIA; NONHUMAN; TREATMENT OUTCOME;

ANIMALIA; CATHARANTHUS ROSEUS; VINCA;

EID: 0036973864     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2002.10819168     Document Type: Article

References (22)

1. Kupchan S., Chakravarti K., Yokoyoma N., (1963) J. Pharm. Sci., 52, 985–988.
2. Mollov N., Dutschewska H., Panov P., (1964) C. R. Acad. Bulg. Sci, 17, 709–712.
3. Mollov N., Dutschewska II., Siljanovska K., Stolchev S., (1968) C. R. Acad. Bulg. Sci., 21, 605–608.
4. Todorov D., Damianova M., (1975) C.R. Acad. Bulg. Sci., 28, 709–711.
5. Todorov D., Deliconstantinos G., (1982). Experientia, 38, 857–859.
6. Todorov D., Zeller W., (1992) J. Cancer Res. Clin. Oncol., 118, 83–86.
7. Broder I., Carter S., (1971) Thalicarpine. Clinical Brochure, Drug. Dev., NCI, Bethesda., USA.
8. Mircheva J., Stoychkov J., (1976) Biomed. Exp., 25, 280–281.
9. Ilarionova M., Maneva K., Todorov D., (1980) C.R. Acad. Bulg. Sci., 33, 719–721.
10. Todorov D., (1988) Drugs of the Future, 13, 234–238.
11. Creaven P., Cohen M., Selawry O., Tjada F., Broder I., (1975) Cancer Chemother. Rep., 59, 1001–1006.
12. Creaven P., Allen L., (1976) Cancer Treat. Rep., 60, 69–75.
13. Christov I., Krusteva E., (1985) In:CMEA- Chemotherapy Symposium, (S., Eckhard, S., Kerpel-Fronius, eds.), Akademiai Kiado, Budapest, 497–502.
14. th Intern. Cancer Congress, Budapest, Abstract452.
15. Arnaudov I., Georgiev G., Petrov M., Serbesova M., (1986) 1st Intern.Symp. Clin. Pharmacol, Sofia, Abstract13.
16. Potier P., (1989) Seminars in Oncology, 16(Suppl. 4), 2–4.
17. Landini I., Bartolozzi B., Banchetti I., Degli Innocenti A., Nocentini O., Bernabei P., (2001) J. Chemotherapy, 13, 309–315.
18. Zhou X.J., Rahmani R., (1992) Drugs, 44(Suppl 4), 1–16.
19. Cros S., Wrigh M., Morimoto M., Lataste H., Couzinier J.P., (1989) Seminars in Oncology, 16(Suppl. 4), 15–20.
20. Cvyitkovic E., Izzo J., (1992) Drugs, 44(Suppl 4), 36–45.
21. Mosmann T., (1983) J. Immunol. Meth., 65, 55–65.
22. Geran R., Greenberg N., Macdonald M., Schumacher A., Abbot B., (1972) Cancer Chemother. Rept., pt.3, 3, 2, 1–87.